Medication info

Dongkwang Candesartan Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOralExpired
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Light yellowish pink tablet with a convex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201903327 · Approved 2019.05.22 · Insurance code 645906540

This product's status changed to Expired on 2024.05.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This drug should be taken at a consistent time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient’s response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient’s response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, depending on the patient’s tolerability. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used for essential hypertension, a representative disease, and heart failure with impaired left ventricular systolic function. In particular, it is effective for patients with heart failure classified as NYHA class II to IV and with a left ventricular ejection fraction below 40% who require addition to ACE inhibitors treatment or have poor tolerance. Therefore, it is used for the treatment of hypertension and specific heart failure patients.

How to take

Adult dose

This drug should be taken at a consistent time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient’s response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient’s response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, depending on the patient’s tolerability. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus during pregnancy, particularly in the 2nd and 3rd trimesters, so it should be stopped immediately if pregnancy is confirmed. It should not be used in certain patients such as those with allergies to this drug or its ingredients, pregnant women, lactating women, and patients with severe liver impairment. Caution is needed when prescribing this drug to elderly patients, those with impaired kidney function, or patients with hyperkalemia, and regular monitoring of blood pressure and kidney function is essential. Side effects such as dizziness, back pain, and respiratory infections may occur while taking this medication, so caution is necessary. Heart failure patients are at risk for hypotension, hyperkalemia, and impaired kidney function, so regular blood tests to monitor their condition are required. Since blood pressure may fall too low or kidney function may worsen, special attention must be given to patients on dialysis or those taking diuretics or suffering from hyponatremia to carefully monitor dosage and conditions. When taken with other antihypertensive agents, this medication may increase blood pressure-lowering effects, so it should be used following a physician's direction. It is advisable for pregnant or nursing women not to take this medication, and if it is absolutely necessary, they must consult professionals. Safety in children and adolescents under 18 has not been established, so its use is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and appropriate medical treatment should be sought immediately.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • paresthesia
  • dyspepsia
Show 69 more
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • increased myoglobin
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • decreased appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the effectiveness and safety of the medication over a long period.

Appearance and packaging

Appearance

Light yellowish pink tablet with a convex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.